High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

NCT02114346 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Contrast-Induced Nephropathy

Interventions

DRUG: Atorvastatin
DRUG: Placebo
DRUG: 0.9% sodium chloride

Sponsor

Isfahan University of Medical Sciences